# C_2008239EN.01002201.xml

| 18.9.2008 | EN | Official Journal of the European Union | C 239/22 |
| --- | --- | --- | --- |

18.9.2008

EN

Official Journal of the European Union

C 239/22

---

Prior notification of a concentration

(Case COMP/M.5325 — Alliance Boots/Megapharm)

Candidate case for simplified procedure

(Text with EEA relevance)

(2008/C 239/11)

| 1. | On 9 September 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Alliance Boots Holdings Ltd (‘Alliance Boots’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Megapharm GmbH Pharmazeutische Erzeugnisse (‘Megapharm’, Germany) by way of purchase of shares. |
| --- | --- |

1.

On 9 September 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Alliance Boots Holdings Ltd (‘Alliance Boots’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Megapharm GmbH Pharmazeutische Erzeugnisse (‘Megapharm’, Germany) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for Alliance Boots: wholesaling of pharmaceutical products and retailing of health and beauty products, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Alliance Boots: wholesaling of pharmaceutical products and retailing of health and beauty products,

| — | for Megapharm: wholesaling of pharmaceutical products for the oncology sector and the provision of related services in Germany. |
| --- | --- |

—

for Megapharm: wholesaling of pharmaceutical products for the oncology sector and the provision of related services in Germany.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5325 — Alliance Boots/Megapharm, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5325 — Alliance Boots/Megapharm, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

(2)  OJ C 56, 5.3.2005, p. 32.

2

---